Home » The story of the patient who will receive lifelong compensation after suffering damage from the AstraZeneca vaccine

The story of the patient who will receive lifelong compensation after suffering damage from the AstraZeneca vaccine

by admin
The story of the patient who will receive lifelong compensation after suffering damage from the AstraZeneca vaccine

37-Year-Old Receives Lifetime Compensation After Adverse Reaction to AstraZeneca Vaccine

A 37-year-old man from Genoa will receive a lifetime compensation of 1740.77 euros after a causal link was established between his anti-Covid vaccination and immune-mediated thrombocytopenia. The man experienced serious adverse reactions following administration of the AstraZeneca vaccine, leading to his hospitalization and ongoing medical treatments.

The consumer association, Codacons, helped the man seek legal assistance after he experienced a hematoma and other symptoms following his vaccination in 2021. The Military Legal Medicine Department of La Spezia confirmed the causal link between the vaccination and the man’s health problems, leading to the approval of compensation by the Local Health Authority 3 of Genoa and the Hospital Medical Commission of La Spezia.

This news comes in light of AstraZeneca’s decision to withdraw its Covid-19 vaccine worldwide, not for safety reasons but due to the availability of other updated vaccines. The compensation granted to the Genoese man serves as a victory in terms of damage from anti-Covid vaccination and highlights the importance of monitoring and addressing adverse reactions to vaccines.

The man will receive bimonthly checks for the rest of his life as compensation for the permanent impairment of his psychophysical integrity. This case serves as a reminder of the potential risks associated with vaccinations and the importance of recognizing and addressing adverse reactions promptly.

See also  Genes and lifestyle as an influencing factor - you can get that old!

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy